Frontlight ResearchEarly access
Heart failure trials in Finland
11 of 14 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 2/3Taking peopleEfficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
- Where
- Tampere
- Age
- 29 days to 17 years
- People
- 342 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT05714085 · EU 2022-501238-52-00 - Phase 3Taking peopleMaridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity (MARITIME-HF)
- Where
- Helsinki, Jyvaskyla, Kuopio, Turku
- Age
- 18 years and over
- People
- 2,787 worldwide
- Run by
- Amgen Inc.
See details and how to join2024-516654-22-00 - Phase 3Taking peopleMaridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Where
- Helsinki, Jyväskylä, Kuopio, Turku
- Age
- 18 years to 99 years
- People
- 5,056 worldwide
- Run by
- Amgen
See details and how to joinNCT07037459 - Phase 3Taking peopleA Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
- Where
- Helsinki
- Age
- Up to 18 years
- People
- 117 worldwide
- Run by
- Bayer
See details and how to joinNCT07192952 · EU 2024-519830-22-00 - Phase 3Taking peopleA Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
- Where
- Helsinki
- Age
- 6 months to 17 years
- People
- 111 worldwide
- Run by
- Bayer
See details and how to joinNCT07188805 · EU 2024-519829-38-00 - Phase 3Taking peopleStudy to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
- Where
- Helsinki, Tampere, Turku
- Age
- 18 years to 130 years
- People
- 3,850 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06307652 · EU 2023-508162-15-00 - No phaseNot yet taking people in FinlandConduction System Pacing vs. Biventricular Pacing for Cardiac Resynchronization Therapy
- Where
- Helsinki
- Age
- 18 years to 99 years
- People
- 1,100 worldwide
- Run by
- Copenhagen University Hospital, Rigshospitalet
See details and how to joinNCT07492979 - Phase 3Not yet taking people in FinlandMYTHS - MYocarditis THerapy With Steroids
- Where
- Helsinki
- Age
- 18 years to 69 years
- People
- 288 worldwide
- Run by
- Niguarda Hospital
See details and how to joinNCT05150704 - Phase 2Taking peopleEffect of Xenon on Brain Injury After Aneurysmal Subarachnoid Hemorrhage
- Where
- Helsinki, Kuopio, Tampere, Turku
- Age
- 18 years and over
- People
- 160 worldwide
- Run by
- Turku University Hospital
See details and how to joinNCT04696523 - No phaseTaking peopleAtrial Fibrillation Ablation Versus Atrioventricular Nodal Ablation with Conduction System Pacing in Heart Failure
- Where
- Helsinki
- Age
- 60 years and over
- People
- 220 worldwide
- Run by
- University Hospital, Geneva
See details and how to joinNCT06207383 - No phaseTaking peopleAtrial Appendage Micrograft Transplants to Assist Heart Repair After Cardiac Surgery
- Where
- Helsinki
- Age
- 18 years to 75 years
- People
- 50
- Run by
- Hospital District of Helsinki and Uusimaa
See details and how to joinNCT05632432